Medical devices industry M&A deals in Q3 2020 total $89.65bn in US

5 November 2020 (Last Updated November 5th, 2020 20:15)

Medical devices industry M&A deals in Q3 2020 total $89.65bn in US

Total medical devices industry M&A deals in Q3 2020 worth $89.65bn were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 4882.8% over the previous quarter and a rise of 2617.5% when compared with the last four-quarter average of $3.3bn.

The US held a 98.3% share of the global medical devices industry M&A deal value that totalled $91.21bn in Q3 2020.

In terms of deal activity, the US recorded 57 deals during Q3 2020, marking a rise of 11.8% over the previous quarter and a rise of 3.6% over the last four-quarter average.

The US medical devices industry M&A deals in Q3 2020: Top deals

The top five medical devices industry M&A deals accounted for 98.05% of the overall value during Q3 2020.

The combined value of the top five medical devices M&A deals stood at $87.9bn, against the overall value of $89.65bn recorded for the month.

The top five medical devices industry deals of Q3 2020 tracked by GlobalData were:

1) Vilex in Tennessee’s $62bn acquisition of DT MedTech

2) The $16.4bn acquisition of Varian Medical Systems by Siemens Healthineers

3) Illumina’s $8bn acquisition of Grail

4) The $780m acquisition of Advanced Instruments by Patricia Industries

5) The merger of Healthcare Merger and SOC Telemed for $720m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.